Egypt vs Mongolia: Share of people with HIV who receive antiretroviral therapy
Egypt
45.0%
in 2024
Mongolia
41.0%
in 2024
Egypt rank
129th
Mongolia rank
131st
Share of people with HIV who receive antiretroviral therapy over time
- Egypt
- Mongolia
How they compare
Egypt currently reports 45.0% against 41.0% in Mongolia, a difference of 4.0%.
That makes Egypt's figure about 1.1 times Mongolia's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Mongolia ahead.
Egypt ranks 129th and Mongolia ranks 131st of 143 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.6% | 0.7% | 0.1% | Mongolia |
| 2010s | 9.9% | 22.9% | 13.0% | Mongolia |
| 2020s | 34.4% | 38.6% | 4.2% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Egypt or Mongolia?
- Egypt, at 45.0% against 41.0% in Mongolia as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Egypt and Mongolia?
- 4.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Mongolia?
- 25 years are reported by both, from 2000 to 2024.
- How do Egypt and Mongolia rank globally for share of people with hiv who receive antiretroviral therapy?
- Egypt ranks 129th and Mongolia ranks 131st of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.